Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Jan 4, 2008
Insider Transaction Report
Form 4
Burshtine Michael
Senior VP and CFO
Transactions
- Sale
Common Stock
2008-01-03$34.02/sh−4,546$154,655→ 0 total - Exercise/Conversion
Common Stock
2008-01-03$6.19/sh+6,335$39,214→ 6,335 total - Exercise/Conversion
Common Stock
2008-01-03$13.75/sh+4,546$62,508→ 4,546 total - Exercise/Conversion
Common Stock
2008-01-02$6.19/sh+70,091$433,863→ 70,091 total - Sale
Common Stock
2008-01-02$34.45/sh−70,091$2,414,635→ 0 total - Sale
Common Stock
2008-01-03$34.01/sh−6,335$215,453→ 0 total - Exercise/Conversion
Stock Option
2008-01-03−70,091→ 32,665 totalExercise: $6.19From: 2006-04-26Exp: 2015-01-13→ Common Stock (70,091 underlying)